Focus Areas

Innovative Neuro Research

Epilepsy

Recurrent, spontaneous seizures

  • Blocking the development of epilepsy & stopping seizures
  • Post traumatic epilepsy
  • Innovative techniques to reproduce human epilepsies in the lab

Neurodegeneration

Loss of neurons in the brain

  • New model development
  • Traumatic Brain Injury
  • Alzheimer's Disease
  • Parkinson's Disease

Imaging

Innovative techniques to illuminate neurological challenges

  • Neurodegenerative diseases
  • Epilepsy
  • Traumatic brain injury

Other Research

Active interest in:

  • Biomarker development
  • Non-invasive Nuerostimulation
  • Human microbiome (“the Second Brain”)

Patents Pending

0
Current Projects at Expesicor
0
People with Epilepsy
0
Traumatic Brain Injury (TBI) cases each year
0
People with Alzheimer's and Parkinson's
Meet the Team

Expesicor Leadership

Braxton Norwood PhD
CEO
Neuroscientist with substantial experience in epilepsy R&D. NIH Young Investigator Award. CURE Foundation Challenge Award.
David Booth
COO
Serial entrepreneur and investor
David Henshall PhD
Scientific Advisory Board
Felix Rosenow MD
Scientific Advisory Board
Matthew Walker MD
Scientific Advisory Board
Matthias Schönberger PhD
Scientific Advisory Board
Thomas Rau PhD
Scientific Advisory Board
Tally Largent-Milnes PhD
Scientific Advisory Board
Expect a response within 48 hours
Contact Us

“Epilepsy R&D is long overdue for a breakthrough, and the KaL method may be just that.”

Tom Swanson, MD, Director of the MT Comprehensive Epilepsy Center